Cholestyramine
NDC 49884-466, cholestyramine, powder, for suspension, from Par Health USA, LLC.
- Product NDC
- 49884-466
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077203
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49884-466 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/5g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49884-466-50 | 49884046650 | 210 g in 1 BOTTLE (49884-466-50) |
| 49884-466-65 | 49884046665 | 60 PACKET in 1 CARTON (49884-466-65) / 5 g in 1 PACKET (49884-466-63) |
| 49884-466-67 | 49884046667 | 210 g in 1 CAN (49884-466-67) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b0c65058-22c3-4f57-9b61-9bc6fcd6e240NADAC price for package 49884046665
GET /v1/drugs/nadac/49884046665NADAC price for package 49884046667
GET /v1/drugs/nadac/49884046667
Use it
Look up 49884-466 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49884-466 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49884-466. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.